MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ)

$10.3 -0.02 (-0.1938%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 76

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ) News Sources

Monte Rosa Therapeutics (GLUE): Best Growth Stocks Under $20 to Buy

03-06-2026

yahoo.com

After a 400% Surge, Should Investors Care About This $882,000 Monte Rosa Insider Sale?

29-06-2026

fool.com

Monte Rosa Therapeutics (GLUE) Is Down 30.7% After Deepening Q2 Losses And H1 Earnings Reversal

07-08-2026

yahoo.com

Monte Rosa Therapeutics Announces First Patient Dosed in MODeFIRe-1, a Phase 2 Study of MRT-2359 in Combination with Apalutamide in Patients with AR Mutation-Positive Metastatic Castration-Resistant Prostate Cancer

24-08-2026

yahoo.com

Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences

01-09-2026

yahoo.com

Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)

08-09-2026

yahoo.com

Novartis (NVS) Just Handed Monte Rosa (GLUE) A $50M Milestone

13-09-2026

yahoo.com

Monte Rosa Therapeutics Announces Positive Results for MRT-8102 in GFORCE-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of ASCVD in Subjects with Elevated CVD Risk

01-10-2026

yahoo.com

Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02-10-2026

yahoo.com

Monte Rosa's MRT-8102 Shows Biomarker Gains in GFORCE-1 Study

06-10-2026

marketbeat.com

MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ) Sentiment Trend

0 25 50 75 100 91 93 43 73 82 66 87 79 73 75 03-06-2026 29-06-2026 07-08-2026 24-08-2026 01-09-2026 08-09-2026 13-09-2026 01-10-2026 02-10-2026 06-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ) FAQs

toggle

What is the current price of MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ)?

The current price of MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ) is $10.3.


toggle

MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ) absolute price change since previous trading day?

The absolute price change of MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ) since the previous trading day is $-0.02.


toggle

MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ) percentage price change since previous trading day?

The percentage price change of MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ) since the previous trading day is -0.1938%.


toggle

What is the most recent average sentiment score for MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ)?

The most recent average sentiment score for MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ) is 76 out of 100.


toggle

What is the most recent average sentiment for MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ)?

The most recent sentiment for MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ) is .


SEC-8K** Filing Available For MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.